Reorganization of HAS structure in France

30

Nov 2021

The new Department of Evaluation and Access to Innovation will be responsible for the assessment of health technologies as well as public health. The strategic priorities of the Department are the following:

  • Implementation of new systems for early access to health products and organization of their monitoring in real life;
  • Setting up an integrated assessment of health products combining medico-technical and medico-economic components;
  • Involvement in developing evaluation methods at the international level;
  • Improvement of evaluation of vaccines and public health.

The DEAI includes four services (drug evaluation service, device evaluation service, evaluation service for procedures, public health and vaccine evaluation service) and two coordination units (coordination unit on real-life data, medico-economic coordination unit).

Because of global changes in health care due to the COVID-19 pandemic, the HAS aims to make more use of its expertise and intensify its presence within international bodies. The international mission specific to DEAI is to establish the agency's influence internationally (strengthen its presence and visibility, positioning in European projects, and building an international cooperation strategy).

The reorganization of HAS is part of all the reflections undertaken by the institution that demonstrates its ability to adapt to changes in health care.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more